CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
1.2358
9.77%
Market Trading Hours* (UTC) Opens on Tuesday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.0184
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.026235 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026235%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004012 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004012%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 1.1258
Open 1.1358
1-Year Change 177.02%
Day's Range 1.1358 - 1.2358
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 9, 2024 1.2358 0.1000 8.80% 1.1358 1.2358 1.1358
Sep 6, 2024 1.1258 -0.0500 -4.25% 1.1758 1.1858 1.1158
Sep 5, 2024 1.1758 0.0300 2.62% 1.1458 1.1758 1.1458
Sep 4, 2024 1.1558 -0.0300 -2.53% 1.1858 1.1858 1.1558
Sep 3, 2024 1.2058 -0.0800 -6.22% 1.2858 1.2858 1.1758
Aug 30, 2024 1.2958 0.0400 3.19% 1.2558 1.2958 1.2458
Aug 29, 2024 1.2658 -0.0500 -3.80% 1.3158 1.3158 1.2658
Aug 28, 2024 1.2758 -0.0300 -2.30% 1.3058 1.3158 1.2358
Aug 27, 2024 1.3258 -0.0100 -0.75% 1.3358 1.3758 1.3058
Aug 26, 2024 1.3558 0.0700 5.44% 1.2858 1.3858 1.2858
Aug 23, 2024 1.2858 0.0600 4.89% 1.2258 1.2858 1.2258
Aug 22, 2024 1.2158 -0.0600 -4.70% 1.2758 1.2858 1.2158
Aug 21, 2024 1.2758 0.0700 5.81% 1.2058 1.2858 1.2058
Aug 20, 2024 1.2058 -0.0500 -3.98% 1.2558 1.2658 1.1958
Aug 19, 2024 1.2758 0.0300 2.41% 1.2458 1.2958 1.2358
Aug 16, 2024 1.2358 -0.0500 -3.89% 1.2858 1.2958 1.2158
Aug 15, 2024 1.2958 0.0100 0.78% 1.2858 1.3058 1.2758
Aug 14, 2024 1.2758 -0.0400 -3.04% 1.3158 1.3258 1.2658
Aug 13, 2024 1.3058 0.0000 0.00% 1.3058 1.3358 1.2658
Aug 12, 2024 1.3058 0.0700 5.66% 1.2358 1.3058 1.2358

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Ocugen, Inc. Company profile

Ocugen (OCGN) is a biopharmaceutical company focusing on discovering, developing, and commercialising gene therapies to cure blindness illnesses and creating a Covid-19 vaccine. 

Founded in 2006, Ocugen became a public company in 2014. The company’s shares are traded on the Nasdaq under the symbol OCGN.

Projects in the pipeline are Covid-19 vaccines, a Modifier Gene Therapy Platform and Novel Biologic Therapies for Retinal Diseases. 

For the Covid-19 vaccine, the company, in collaboration Bharat Biotech, was developing, manufacturing and commercialising COVAXIN for the prevention of the disease for US and Canada markets. COVAXIN is a whole-virion inactivated Covid-19 vaccine candidate and is formulated with the inactivated SARS-CoV-2 virus.

The Modifier Gene Therapy Platform is designed for retinal diseases, including retinitis pigmentosa (RP), leber congenital amaurosis (LCA) and dry age-related macular degeneration (AMD). The technology is licensed from the Schepens Eye Research Institute of Massachusetts Eye and Ear (Harvard Medical School).

The company is developing OCU200, a biologic product candidate for the treatment of severe vision-threatening diseases such as diabetic macular edema (DME), diabetic retinopathy (DR), and wet age-related macular degeneration (Wet-AMD). 

Patients affected by these diseases have common symptoms, such as blurry vision and increasing visual loss as the condition develops.

Another technology in the pipeline is OCU400, the company’s first product candidate developed with its Modifier Gene Therapy Platform.

Ocugen is headquartered in Malvern, Pennsylvania.

Industry: Biotechnology & Medical Research (NEC)

11 Great Valley Parkway
MALVERN
PENNSYLVANIA 19355
US

News

Introducing Newsquawk: your new in-platform newsfeed

We are very excited to announce the launch of Newsquawk in the Capital.com platform and app. This new newsfeed is designed to help you get ahead with real-time headlines, personalised stories and in-depth reports – all available directly in the platform and app, where you need them.

14:09, 20 August 2024

Jackson Hole Preview: All eyes on Powell and Gold

The key focus this week will be on Jerome Powell and any insight he may give into the future of monetary policy.

15:24, 19 August 2024

All eyes on inflation: US and UK CPI take centre stage

Just over a month has gone by since the latest CPI data was released in the US and so much has happened since.

14:41, 13 August 2024

European stocks face resistance in their attempt to recover

European stocks struggle to recover as the tech sector faces continued downside pressure in Asia.

13:56, 9 August 2024

Global selloff continues on US economy fears

Thursday’s rise in jobless claims led to a market meltdown in the US stock market as investors became concerned that the Federal Reserve made the wrong decision by keeping rates unchanged on Wednesday.

14:40, 5 August 2024

FOMC PREVIEW

Markets believe the Federal reserve will continue to leave their monetary policy unchanged at the meeting next week.

14:09, 1 August 2024

How to manage risk when trading

Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.

06:57, 22 July 2024

People also watch

BTC/USD

56,667.15 Price
-0.770% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Gold

2,501.84 Price
-0.160% 1D Chg, %
Long position overnight fee -0.0192%
Short position overnight fee 0.0110%
Overnight fee time 21:00 (UTC)
Spread 0.30

Oil - Crude

68.10 Price
-0.330% 1D Chg, %
Long position overnight fee 0.0243%
Short position overnight fee -0.0463%
Overnight fee time 21:00 (UTC)
Spread 0.040

XRP/USD

0.54 Price
-0.720% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 640,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading